Brind.

Recursion Pharmaceuticals and Organon & Co. both reported positive Earnings ESP on July 22, 2025.

1 report, 1 independent Updated Jul 22

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Recursion (United States)Organon & Co.

Keep exploring

The entities involved

Recursion (United States)
company in Salt Lake City, United States
- Recursion (United States) disclosed insider trading via required filings with the SEC on June 6, 2026.Sun 17:12
- Trump's pledge to unleash oil and gas benefits stocks, involving Willis Towers Watson.Sun 05:14
Organon & Co.
pharmaceutical company
- Organon & Co. and Spero Therapeutics Inc., two healthcare companies, are currently competing for investment opportunities.Wed 11:24

Coverage

Newest first; wire copies grouped

Jul 22ZacksThese 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter,